Redx Pharma Plc
PrivateLast Round
Series A
Aug 14, 2026
Est. Valuation
$214.65M
Total Funding Raised
$29M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Redx Pharma Plc is a clinical-stage biotechnology company that discovers and develops novel, small molecule, targeted medicines for the treatment of fibrotic disease and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redx Pharma Plc Comparables
Compare Redx Pharma Plc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Graviton BioScience | 81% | |
| Vicore Pharma | 78% | |
| Contineum Therapeutics | 75% |
Redx Pharma Plc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 14, 2026 | ||||
| Private Placement | Oct 18, 2023 | ||||
| Private Placement | May 19, 2022 | ||||
| Private Placement | Dec 2, 2020 | ||||
| Convertible Debt | Aug 4, 2020 | ||||
Private Placement | Jul 21, 2020 |
Key People
Founding team and executive leadership
Redx Pharma Plc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Convertible Debt, Private Placement, Series A |
| Polar Capital | Private Placement |
| Platinum Asset Management | Private Placement |
| British Business Bank | Series A |
| Abingworth | Series A |
| Sofinnova Partners | Convertible Debt, Private Placement |
| Invus | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2026
$36M round led by Abingworth.
- Jan 21, 2026
Monthly visitors increased 50% MoM, reaching 6.6K.
Redx Pharma Plc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Redx Pharma Plc's valuation, stock price, and market status.
Is Redx Pharma Plc a public or private company?
Redx Pharma Plc is a private company.
What is the current stock price of Redx Pharma Plc?
Redx Pharma Plc is a private company with no public stock price. No recent secondary market data is available.
How much is Redx Pharma Plc worth (valuation)?
Redx Pharma Plc's valuation is estimated at $30.0M based on funding round data.
Can I buy Redx Pharma Plc stock?
Redx Pharma Plc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Redx Pharma Plc's last funding round?
Redx Pharma Plc's most recent funding round was Private Placement on March 4, 2020.
Who are the main investors in Redx Pharma Plc?
Key investors in Redx Pharma Plc include Redmile Group, Sofinnova Partners.
Will Redx Pharma Plc IPO soon?
No public IPO plans have been announced for Redx Pharma Plc.
How can I track Redx Pharma Plc secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Redx Pharma Plc's secondary market activity and sign up for updates.